{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T17:22:08Z","timestamp":1785864128100,"version":"3.56.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,11]],"date-time":"2021-09-11T00:00:00Z","timestamp":1631318400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["PPM-00259-15"],"award-info":[{"award-number":["PPM-00259-15"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["APQ-04347-17"],"award-info":[{"award-number":["APQ-04347-17"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007375","name":"Pr\u00f3-Reitoria de Pesquisa, Universidade Federal de Minas Gerais","doi-asserted-by":"publisher","award":["88881.068501\/2014-01"],"award-info":[{"award-number":["88881.068501\/2014-01"]}],"id":[{"id":"10.13039\/501100007375","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["303478\/2012-8"],"award-info":[{"award-number":["303478\/2012-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["448060\/2014-0"],"award-info":[{"award-number":["448060\/2014-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["PQ 306939\/2015-0"],"award-info":[{"award-number":["PQ 306939\/2015-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jare.2021.09.003","type":"journal-article","created":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T11:41:41Z","timestamp":1631533301000},"page":"285-298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Calix[n]arene-based immunogens: A new non-proteic strategy for anti-cocaine vaccine"],"prefix":"10.1016","volume":"38","author":[{"given":"Leonardo","family":"da Silva Neto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang\u00e9lica Faleiros","family":"da Silva Maia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana Martins","family":"Godin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo S\u00e9rgio","family":"de Almeida Augusto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raissa Lima Gon\u00e7alves","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sordaini Maria","family":"Caligiorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemeire Brondi","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone Od\u00edlia Antunes","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valbert Nascimento","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisele Assis Castro","family":"Goulart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe Terra","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maila de Castro Louren\u00e7o","family":"das Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederico Duarte","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c2ngelo","family":"de F\u00e1tima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jare.2021.09.003_b0005","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1300\/J069v12n02_08","article-title":"Current pharmacotherapies for cocaine abuse: a review","volume":"12","author":"Tutton","year":"1993","journal-title":"J Addict Dis"},{"issue":"8","key":"10.1016\/j.jare.2021.09.003_b0010","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1046\/j.1360-0443.2002.00209.x","article-title":"Pharmacological treatment of cocaine dependence: a systematic review","volume":"97","author":"de Lima","year":"2002","journal-title":"Addiction"},{"issue":"03","key":"10.1016\/j.jare.2021.09.003_b0015","doi-asserted-by":"crossref","DOI":"10.1017\/S1461145707008097","article-title":"New treatments for cocaine dependence: a focused review","volume":"11","author":"Karila","year":"2008","journal-title":"Int J Neuropsychoph"},{"issue":"1","key":"10.1016\/j.jare.2021.09.003_b0020","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2174\/1874473711003010049","article-title":"Review of treatment for cocaine dependence","volume":"3","author":"Penberthy","year":"2010","journal-title":"Curr Drug Abuse Rev"},{"issue":"2","key":"10.1016\/j.jare.2021.09.003_b0025","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/002204269102100206","article-title":"Social processes of initiation into crack","volume":"21","author":"Fagan","year":"1991","journal-title":"J Drug Issues"},{"issue":"2","key":"10.1016\/j.jare.2021.09.003_b0030","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/16066359409109139","article-title":"Who uses cocaine? Social profiles of cocaine users","volume":"2","author":"Green","year":"1994","journal-title":"Addict Res"},{"issue":"3","key":"10.1016\/j.jare.2021.09.003_b0035","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF03403687","article-title":"Crack use as a public health problem in Canada","volume":"96","author":"Haydon","year":"2005","journal-title":"Can J Public Health"},{"issue":"3","key":"10.1016\/j.jare.2021.09.003_b0040","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1590\/S1516-44462006000300010","article-title":"Causes of death among crack cocaine users","volume":"28","author":"Ribeiro","year":"2006","journal-title":"Braz J Psychiatry"},{"issue":"13","key":"10.1016\/j.jare.2021.09.003_b0045","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.3109\/10826081003682883","article-title":"Crack cocaine use in Barcelona: a reason of worry","volume":"45","author":"Oliveira","year":"2010","journal-title":"Subst Use Misuse"},{"issue":"1","key":"10.1016\/j.jare.2021.09.003_b0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1517\/14728214.2015.985203","article-title":"Emerging drugs for the treatment of cocaine use disorder: a review of neurobiological targets and pharmacotherapy","volume":"20","author":"Shorter","year":"2015","journal-title":"Expert Opin Emerg Dr"},{"key":"10.1016\/j.jare.2021.09.003_b0055","unstructured":"United Nations Office on Drugs and Crime (UNODC). World Drug Report 2019. https:\/\/wdr.unodc.org\/wdr2019\/prelaunch\/WDR19_Booklet_4_STIMULANTS.pdf United Nations, New York, 2019. Assessed 06\/30\/2021."},{"issue":"4","key":"10.1016\/j.jare.2021.09.003_b0060","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1590\/1516-4446-2017-2409","article-title":"Active Brazilian crack cocaine users: nutritional, anthropometric, and drug use profiles","volume":"40","author":"Escobar","year":"2018","journal-title":"Braz J Psychiatry"},{"issue":"2","key":"10.1016\/j.jare.2021.09.003_b0065","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jped.2017.12.016","article-title":"Telephone counseling for young Brazilian cocaine and\/or crack users. Who are these users?","volume":"95","author":"Bisch","year":"2019","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.jare.2021.09.003_b0070","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1590\/2237-6089-2017-0143","article-title":"Adulterants in crack cocaine in Brazil","volume":"41","author":"Ribeiro","year":"2019","journal-title":"Trends Psychiatry Psychother"},{"issue":"1","key":"10.1016\/j.jare.2021.09.003_b0075","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.addbeh.2013.10.019","article-title":"Prevalence of cocaine use in Brazil: Data from the II Brazilian National Alcohol and Drugs Survey (BNADS)","volume":"39","author":"Abdalla","year":"2014","journal-title":"Addict Behav"},{"issue":"3","key":"10.1016\/j.jare.2021.09.003_b0080","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1124\/pr.115.011668","article-title":"Evaluation of the \u201cpipeline\u201d for development of medications for cocaine use disorder: a review of translational preclinical, human laboratory, and clinical trial research","volume":"68","author":"Czoty","year":"2016","journal-title":"Pharmacol Rev"},{"issue":"2","key":"10.1016\/j.jare.2021.09.003_b0085","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pharmthera.2013.04.011","article-title":"Substance use disorders: Psychoneuroimmunological mechanisms and new targets for therapy","volume":"139","author":"Loftis","year":"2013","journal-title":"Pharmacol Therapeut"},{"issue":"2","key":"10.1016\/j.jare.2021.09.003_b0090","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.biopsych.2005.04.032","article-title":"Vaccine pharmacotherapy for the treatment of cocaine dependence","volume":"58","author":"Martell","year":"2005","journal-title":"Biol Psychiatry"},{"issue":"10","key":"10.1016\/j.jare.2021.09.003_b0095","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/nm1096-1129","article-title":"Efficacy of a therapeutic cocaine vaccine in rodent models","volume":"2","author":"Fox","year":"1996","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.jare.2021.09.003_b0100","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0376-8716(97)00121-X","article-title":"Development of a therapeutic vaccine for the treatment of cocaine addiction","volume":"48","author":"Fox","year":"1997","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.jare.2021.09.003_b0105","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s002130050049","article-title":"Evaluation of anti-cocaine antibodies and a cocaine vaccine in a rat self-administration model","volume":"148","author":"Kantak","year":"2000","journal-title":"Psychopharmacology"},{"issue":"7-8","key":"10.1016\/j.jare.2021.09.003_b0110","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0264-410X(01)00425-X","article-title":"Human therapeutic cocaine vaccine: safety and immunogenicity","volume":"20","author":"Kosten","year":"2002","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.jare.2021.09.003_b0115","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1001\/archgenpsychiatry.2009.128","article-title":"Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients","volume":"66","author":"Martell","year":"2009","journal-title":"Arch Gen Psychiatry"},{"issue":"9","key":"10.1016\/j.jare.2021.09.003_b0120","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1586\/erv.10.102","article-title":"Anti-cocaine vaccine development","volume":"9","author":"Kinsey","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.jare.2021.09.003_b0125","doi-asserted-by":"crossref","first-page":"899","DOI":"10.2174\/187152711799219334","article-title":"Anti-cocaine vaccine based on coupling a cocaine analog to a disrupted adenovirus","volume":"10","author":"Koob","year":"2011","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"17","key":"10.1016\/j.jare.2021.09.003_b0130","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1021\/ja108807j","article-title":"Impact of distinct chemical structures for the development of a methamphetamine vaccine","volume":"133","author":"Moreno","year":"2011","journal-title":"J Am Chem Soc"},{"issue":"8","key":"10.1016\/j.jare.2021.09.003_b0135","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.biopsych.2012.09.010","article-title":"A methamphetamine vaccine attenuates methamphetamine-induced disruptions in thermoregulation and activity in rats","volume":"73","author":"Miller","year":"2013","journal-title":"Biol Psychiatry"},{"issue":"1-2","key":"10.1016\/j.jare.2021.09.003_b0140","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.drugalcdep.2012.09.007","article-title":"A vaccine against methamphetamine attenuates its behavioral effects in mice","volume":"129","author":"Shen","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jare.2021.09.003_b0145","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.intimp.2016.03.028","article-title":"Optimization of a methamphetamine conjugate vaccine for antibody production in mice","volume":"35","author":"Stevens","year":"2016","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"10.1016\/j.jare.2021.09.003_b0150","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/ajad.12867","article-title":"Preclinical efficacy of an anti-methamphetamine vaccine using E6020 adjuvant","volume":"28","author":"Arora","year":"2019","journal-title":"Am J Addict"},{"issue":"14","key":"10.1016\/j.jare.2021.09.003_b0155","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1021\/jm200461m","article-title":"A vaccine strategy that induces protective immunity against heroin","volume":"54","author":"Stowe","year":"2011","journal-title":"J Med Chem"},{"issue":"22","key":"10.1016\/j.jare.2021.09.003_b0160","doi-asserted-by":"crossref","first-page":"9036","DOI":"10.1073\/pnas.1219159110","article-title":"Dynamic vaccine blocks relapse to compulsive intake of heroin","volume":"110","author":"Schlosburg","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jare.2021.09.003_b0165","doi-asserted-by":"crossref","unstructured":"Raleigh MD, Pentel PR, LeSage MG. Pharmacokinetic correlates of the effectsof a heroin vaccine on heroin self-administration in rats. PLoS One 2014; 9(12): e115696.","DOI":"10.1371\/journal.pone.0115696"},{"issue":"25","key":"10.1016\/j.jare.2021.09.003_b0170","doi-asserted-by":"crossref","first-page":"8601","DOI":"10.1021\/jacs.7b03334","article-title":"Development of a clinically viable heroin vaccine","volume":"139","author":"Bremer","year":"2017","journal-title":"J Am Chem Soc"},{"issue":"11","key":"10.1016\/j.jare.2021.09.003_b0175","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1002\/anie.201511654","volume":"55","author":"Bremer","year":"2016","journal-title":"Angew Chem Int Ed"},{"issue":"2","key":"10.1016\/j.jare.2021.09.003_b0180","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1124\/jpet.118.253674","article-title":"A fentanyl vaccine alters fentanyl distribution and protects against fentanyl-induced effects in mice and rats","volume":"368","author":"Raleigh","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jare.2021.09.003_b0185","doi-asserted-by":"crossref","first-page":"107730","DOI":"10.1016\/j.neuropharm.2019.107730","article-title":"Vaccine blunts fentanyl potency in male rhesus monkeys","volume":"158","author":"Tenney","year":"2019","journal-title":"Neuropharmacology"},{"issue":"10","key":"10.1016\/j.jare.2021.09.003_b0190","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0192-0561(00)00042-4","article-title":"Vaccination against nicotine during continued nicotine administration in rats: immunogenicity of the vaccine and effects on nicotine distribution to brain","volume":"22","author":"Hieda","year":"2000","journal-title":"Int J Immunopharmacol."},{"key":"10.1016\/j.jare.2021.09.003_b0195","doi-asserted-by":"crossref","unstructured":"Cornuz J, Zwahlen S, Jungi WF, Osterwalder J, Klingler K, Melle G, et al. A vaccine against nicotine for smoking cessation: a randomized controlled trial. PLoS One 2018; 3:e2547.","DOI":"10.1371\/journal.pone.0002547"},{"issue":"10","key":"10.1016\/j.jare.2021.09.003_b0200","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.vaccine.2009.12.051","article-title":"Nicotine hapten structure, antibody selectivity and effect relationships: Results from a nicotine vaccine screening procedure","volume":"28","author":"de Villiers","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jare.2021.09.003_b0205","doi-asserted-by":"crossref","unstructured":"Pentel PR, LeSage MG. In: Dwoskin LP, editor. Advances in Pharmacology, Vol. 69. Academic Press, City; 2014, pp. 553\u201380.","DOI":"10.1016\/B978-0-12-420118-7.00014-7"},{"issue":"2","key":"10.1016\/j.jare.2021.09.003_b0210","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0960-894X(01)80899-4","article-title":"Phenylphosphonate monoester analogs of cocaine. Potential haptens for the generation of catalytic antibodies","volume":"3","author":"Chandrakumar","year":"1993","journal-title":"Bioorg Med Chem Lett"},{"issue":"6558","key":"10.1016\/j.jare.2021.09.003_b0215","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/378727a0","article-title":"Suppression of psychoactive effects of cocaine by active immunization","volume":"378","author":"Carrera","year":"1995","journal-title":"Nature"},{"issue":"31","key":"10.1016\/j.jare.2021.09.003_b0220","doi-asserted-by":"crossref","first-page":"5479","DOI":"10.1016\/0040-4039(96)01170-7","article-title":"Design and synthesis of a cocaine-diamide hapten for vaccine development","volume":"37","author":"Sakurai","year":"1996","journal-title":"Tetrahedrron Lett"},{"issue":"4","key":"10.1016\/j.jare.2021.09.003_b0225","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1073\/pnas.98.4.1988","article-title":"A second-generation vaccine protects against the psychoactive effects of cocaine","volume":"98","author":"Carrera","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.jare.2021.09.003_b0230","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1021\/mp400214w","article-title":"Probing the effects of hapten stability on cocaine vaccine immunogenicity","volume":"10","author":"Cai","year":"2013","journal-title":"Mol Pharm"},{"issue":"3","key":"10.1016\/j.jare.2021.09.003_b0235","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/cbdd.12326","volume":"84","author":"Ramakrishnan","year":"2014","journal-title":"Chem Biol Drug Des"},{"issue":"3","key":"10.1016\/j.jare.2021.09.003_b0240","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.drudis.2019.07.009","article-title":"Immunotherapy for treating methamphetamine, heroin and cocaine use disorders","volume":"25","author":"Xiaoshan","year":"2020","journal-title":"Drug Discov Today"},{"issue":"5","key":"10.1016\/j.jare.2021.09.003_b0245","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/npp.2011.200","article-title":"Novel cocaine vaccine linked to a disrupted adenovirus gene transfer vector blocks cocaine psychostimulant and reinforcing effects","volume":"37","author":"Wee","year":"2012","journal-title":"Neuropsychopharmacol"},{"issue":"11","key":"10.1016\/j.jare.2021.09.003_b0250","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1038\/npp.2013.114","article-title":"Adenovirus capsid-based anti-cocaine vaccine prevents cocaine from binding to the nonhuman primate CNS dopamine transporter","volume":"38","author":"Maoz","year":"2013","journal-title":"Neuropsychopharmacol"},{"issue":"9","key":"10.1016\/j.jare.2021.09.003_b0255","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1021\/jm400228w","article-title":"Probing active cocaine vaccination performance through catalytic and noncatalytic hapten design","volume":"56","author":"Cai","year":"2013","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.jare.2021.09.003_b0260","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/mt.2010.280","article-title":"Cocaine analog coupled to disrupted adenovirus: A vaccine strategy to evoke high-titer immunity against addictive drugs","volume":"19","author":"Hicks","year":"2011","journal-title":"Mol Ther"},{"issue":"5","key":"10.1016\/j.jare.2021.09.003_b0265","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1021\/acschemneuro.5b00345","article-title":"Suppression of cocaine-evoked hyperactivity by self-adjuvanting and multivalent peptide nanofiber vaccines","volume":"7","author":"Rudra","year":"2016","journal-title":"ACS Chem Neurosci"},{"issue":"2","key":"10.1016\/j.jare.2021.09.003_b0270","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1021\/mp500520r","article-title":"Flagellin as carrier and adjuvant in cocaine vaccine development","volume":"12","author":"Lockner","year":"2015","journal-title":"Mol Pharm"},{"issue":"2","key":"10.1016\/j.jare.2021.09.003_b0275","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/vaccines4020012","article-title":"Recent advances in subunit vaccine carrier","volume":"4","author":"Vartak","year":"2016","journal-title":"Vaccines"},{"issue":"4","key":"10.1016\/j.jare.2021.09.003_b0280","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0952-7915(06)80038-5","article-title":"New carriers and adjuvants in the development of vaccines","volume":"4","author":"Giudice","year":"1992","journal-title":"Curr Opin Immunol"},{"issue":"8","key":"10.1016\/j.jare.2021.09.003_b0285","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1021\/ja057244+","article-title":"Preparation and evaluation of unimolecular pentavalent and hexavalent antigenic constructs targeting prostate and breast cancer: a synthetic route to anticancer vaccine candidates","volume":"128","author":"Ragupathi","year":"2006","journal-title":"J Am Chem Soc"},{"issue":"5138","key":"10.1016\/j.jare.2021.09.003_b0290","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1126\/science.8248784","article-title":"The influence of antigen organization on B cell responsiveness","volume":"262","author":"Bachmann","year":"1993","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.jare.2021.09.003_b0295","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1002\/eji.1830251236","article-title":"T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: Role of antigen patterns in B cell induction?","volume":"25","author":"Bachmann","year":"1995","journal-title":"Eur J Immunol"},{"issue":"5","key":"10.1016\/j.jare.2021.09.003_b0300","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1021\/acs.bioconjchem.5b00103","article-title":"Guiding principles in the design of molecular bioconjugates for vaccine applications","volume":"26","author":"Liu","year":"2015","journal-title":"Bioconjugate Chem"},{"issue":"3","key":"10.1016\/j.jare.2021.09.003_b0305","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1021\/bc700411w","article-title":"Calix[4]arene decorated with four Tn antigen glycomimetic units and P3CS immunoadjuvant: synthesis, characterization, and anticancer immunological evaluation","volume":"19","author":"Geraci","year":"2008","journal-title":"Bioconjugate Chem"},{"issue":"10","key":"10.1016\/j.jare.2021.09.003_b0310","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1021\/bc400242y","article-title":"First self-adjuvant multicomponent potential vaccine candidates by tethering of four or eight MUC1 antigenic immunodominant PDTRP units on a calixarene platform: synthesis and biological evaluation","volume":"24","author":"Geraci","year":"2013","journal-title":"Bioconjugate Chem"},{"issue":"8","key":"10.1016\/j.jare.2021.09.003_b0315","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1016\/j.arabjc.2016.06.013","article-title":"Iminecalix[4]arenes: microwave-assisted synthesis, X-ray crystal structures, and anticandidal activity","volume":"12","author":"da Silva","year":"2019","journal-title":"Arab J Chem"},{"key":"10.1016\/j.jare.2021.09.003_b0320","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/978-1-61779-310-3_19","article-title":"Neuropeptide autoantibodies assay","volume":"789","author":"Fetissov","year":"2011","journal-title":"Methods Mol Biol"},{"issue":"13","key":"10.1016\/j.jare.2021.09.003_b0325","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1021\/ja00403a028","article-title":"4. The synthesis, characterization, and properties of the calixarenes from p-tert-butylphenol","volume":"103","author":"Gutsche","year":"1981","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.jare.2021.09.003_b0330","doi-asserted-by":"crossref","first-page":"234","DOI":"10.15227\/orgsyn.068.0234","article-title":"p-tert-Butylcalix[4]arene","volume":"68","author":"Gutsche","year":"1990","journal-title":"Org Synth"},{"key":"10.1016\/j.jare.2021.09.003_b0335","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2174\/157018012798192991","article-title":"Synthesis and anti-paracoccidioides activity of calix[n]arenes","volume":"9","author":"de Oliveira","year":"2012","journal-title":"Lett Drug Des Discov"},{"issue":"7","key":"10.1016\/j.jare.2021.09.003_b0340","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/(SICI)1521-3765(19980710)4:7<1225::AID-CHEM1225>3.0.CO;2-6","article-title":"Supramolecular materials: Molecular packing of tetranitrotetrapropoxycalix[4]arene in highly stable films with second-order nonlinear optical properties","volume":"4","author":"Kenis","year":"1998","journal-title":"Chem Eur J"},{"issue":"09","key":"10.1016\/j.jare.2021.09.003_b0345","first-page":"1435","article-title":"Synthesis of p-tert-butylcalix[8]arene ether derivatives","volume":"47B","author":"Yi","year":"2008","journal-title":"Indian J Chem"},{"issue":"4","key":"10.1016\/j.jare.2021.09.003_b0350","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1021\/jo00030a050","article-title":"Ipso nitration of p-tert-butylcalix [4] arenes","volume":"57","author":"Verboom","year":"1992","journal-title":"J Org Chem"},{"issue":"50","key":"10.1016\/j.jare.2021.09.003_b0355","doi-asserted-by":"crossref","first-page":"11613","DOI":"10.1016\/j.tet.2004.09.047","article-title":"A general synthesis of water soluble upper rim calix[n]arene guanidinium derivatives which bind to plasmid DNA","volume":"60","author":"Dudic","year":"2004","journal-title":"Tetrahedron"},{"issue":"45","key":"10.1016\/j.jare.2021.09.003_b0360","doi-asserted-by":"crossref","first-page":"14528","DOI":"10.1021\/ja0634425","article-title":"DNA Condensation and cell transfection properties of guanidinium calixarenes: dependence on macrocycle lipophilicity, size, and conformation","volume":"128","author":"Sansone","year":"2006","journal-title":"J Am Chem Soc"},{"issue":"26","key":"10.1016\/j.jare.2021.09.003_b0365","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1021\/ol0361002","article-title":"Supramolecular structures formed by calix[8]arene derivatives","volume":"5","author":"Podoprygorina","year":"2003","journal-title":"Org Lett"},{"issue":"4","key":"10.1016\/j.jare.2021.09.003_b0370","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1021\/ja1086112","article-title":"Bivalent inhibitors for disrupting protein surface-substrate interactions and for dual inhibition of protein prenyltransferases","volume":"133","author":"Machida","year":"2011","journal-title":"J Am Chem Soc"},{"issue":"11","key":"10.1016\/j.jare.2021.09.003_b0375","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1021\/ja01640a001","article-title":"The three-dimensional structure of the cocaines. Part I. Cocaine and pseudococaine","volume":"76","author":"Findlay","year":"1954","journal-title":"J Am Chem Soc"},{"issue":"12","key":"10.1016\/j.jare.2021.09.003_b0380","first-page":"2069","article-title":"Biodistribution and dosimetry of TRODAT-1: a technetium-99m tropane for imaging dopamine transporters","volume":"39","author":"Mozley","year":"1996","journal-title":"J Nucl Med"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123221001715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123221001715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:50:31Z","timestamp":1778835031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123221001715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":76,"alternative-id":["S2090123221001715"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2021.09.003","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Calix[n]arene-based immunogens: A new non-proteic strategy for anti-cocaine vaccine","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2021.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}